Octagam (intravenous normal human immunoglobulin) / Octapharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
NCT00812565 / 2007-007134-19: Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

Completed
2
58
US
Placebo, octagam 10%, IVIG
Octapharma
Alzheimer's Disease
09/10
09/10
NCT02690038: Ig PRx in AECOPD: Pilot Study

Completed
2
48
Canada
Intravenous immunoglobulin (IVIG), Gamunex, CBS IGIV-nex, Privigen, Octagam, Normal Saline, Saline, Sodium Chloride
Ottawa Hospital Research Institute, CSL Behring, Grifols Biologicals, LLC
Chronic Obstructive Pulmonary Disease
11/19
11/19

Download Options